Format

Send to

Choose Destination
See comment in PubMed Commons below
Presse Med. 2007 Sep;36(9 Pt 2):1319-25. Epub 2007 May 23.

[Endocrine consequences of hemochromatosis].

[Article in French]

Author information

1
Service d'endocrinologie et des maladies de la reproduction, CHU de BicĂȘtre, UniversitĂ© Paris Sud 11, Le Kremlin-BicĂȘtre. Jacques.young@bct.aphp.fr

Abstract

The two most frequent endocrine complications of hemochromatosis are diabetes mellitus and hypogonadotrophic hypogonadism. Other endocrine disorders related to this disease are very rare and are described especially in the most severe and earliest posttransfusion iron overloads. Endocrine complications are evidence of advanced hemochromatosis, often already associated with cirrhosis. Given the low frequency of HFE mutations in type 2 diabetes, routine genetic testing in this population does not seem reasonable. Testing for iron overload is recommended in subjects with atypical type 2 diabetes (for example, patients who are not overweight) and in cases of hypogonadism, characteristic pigmentation, or cirrhosis. Phlebotomy plays an important role in the management of endocrine complications of hemochromatosis, especially when diagnosis is early. In all cases of hypogonadotrophic hypogonadism, primary hemochromatosis must be considered.

PMID:
17524608
DOI:
10.1016/j.lpm.2007.01.041
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center